Luminescence-Based tRNA Modification Assay for Modulator Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing the efficacy of tRNA modifying enzymes modulators are either cell-free, complex, or require substantial equipment and expertise, making it challenging to identify modulators in a reliable, less costly, and efficient manner.

Innovation Solution

A luminescence-based assay using stably transformed human cell lines with repetitions of tRNA modification-sensitive codons upstream of a first luminescence-based reporter gene and synonymous codons upstream of a second luminescence-based reporter gene to rapidly identify modulators of tRNA modifying enzymes, allowing for tRNA modification modulator screening.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If cell-free methods are used to assess tRNA modifying enzyme modulators, then the assay can be performed without living cells, but the method becomes complex and requires substantial equipment and expertise

Engineering Contradiction:
Improveassay reliabilityVSAvoidassay complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces complex cell-free biochemical systems with a simpler cell-based luminescence assay system. Instead of using cell-free extracts that require sophisticated equipment for protein synthesis measurement, the invention uses living cells that naturally perform translation, coupled with a luminescence reporter system that provides easy-to-measure signals through standard plate readers.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates a simplified copy of the translation process using reporter genes with codon repetitions. Rather than measuring actual protein synthesis in complex cell-free systems, the invention uses luminescence reporter constructs that replicate the translation challenge in a controlled, measurable way, allowing modulator effects to be detected through luminescence intensity changes.

Inventive Principle:
Principle #26Copying

2Measurement precision

If complex methods with substantial equipment are used, then measurement precision can be improved, but the cost and ease of operation deteriorate

Engineering Contradiction:
Improvemodulator detection precisionVSAvoidassay ease of operation
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent substitutes complex equipment-dependent measurement systems with a luminescence-based detection system. Luminescence readings can be performed using standard plate readers or luminometers that are more accessible and easier to operate than the specialized equipment required for cell-free protein synthesis assays, while maintaining sufficient precision for modulator detection.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs disposable luminescence reporter constructs and cell-based systems that can be quickly prepared and discarded, eliminating the need for expensive, maintenance-intensive equipment. The assay uses readily available reagents and cell lines that can be processed through simple protocols, reducing both equipment costs and operational complexity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of operation

If cell-based assays with luminescence reporters are used, then ease of operation and cost-effectiveness are improved, but the assay duration and time required for results increase

Engineering Contradiction:
Improveassay ease of operationVSAvoidassay time
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The patent incorporates luminescence reporter genes with tRNA modification-sensitive codon repetitions directly into the assay construct before cell treatment. This preliminary setup allows the cells to be pre-prepared with the reporting system, so that when modulators are added, the effect can be measured relatively quickly without requiring time-consuming setup procedures during the actual assay execution.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses periodic luminescence reading cycles to monitor translation changes. Instead of continuous monitoring, the assay employs discrete time-point measurements where luminescence is read at specific intervals after modulator addition, allowing for efficient time management and reducing total assay duration while maintaining detection precision.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables fast, cost-effective, and reproducible detection of tRNA modification modulators, specifically useful in controlling cancer development and acquired resistance, without the need for extensive computational or experimental resources.

Implementation Method 1

A luminescence-based assay using stably transformed human cell lines with repetitions of tRNA modification-sensitive codons upstream of a first luminescence-based reporter gene

Methodology Applied
Scientific EffectLuminescence: Luminescence

Data Source

PatentUS20240376555A1Tnra modification-sensitive codon translation assay comprising luminescence-based reporter system
Publication Date: 2024.11.14 VAL
  • US20240376555A1 patent drawing

AI summary

An assay using stably transformed human cell lines comprising repetitions of codons sensitive to tRNA modifications upstream of a first luminescence-based reporter gene and repetitions of their synonymous codons upstream of a second luminescence-based reporter gene is helpful in rapidly identifying modulators of tRNA modifying enzymes.